The Noramco Group is investing $25M into its Halo Pharma facility in Whippany, NJ to establish sterile injectable ...
Q4 2024 Earnings Call Transcript March 6, 2025 Stevanato Group S.p.A. reports earnings inline with expectations. Reported EPS ...
The expansion addresses US injectable capacity shortages and growing demand for reliable domestic sterile manufacturing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback